С П И С Ъ К

на цитиранията

на д-р Нойко Стефанов Станилов, д.х.

Цитирана статия:

Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stanilov

NS. High interleukin 12 and low interleukin 10 production after in vitro stimulation

detected in sepsis survivors.INTENSIVE CARE MEDICINE 31 (3): 401-407 MAR 2005

Цитиращи автори и статии:

1. Song GY, Chung CS, Rhee RJ, et al. Loss of signal transducer and activator of

transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in

sepsis. INTENSIVE CARE MEDICINE 31 (11): 1564-1569 NOV 2005 (IF2005=3.724)

2. Georgieva GS, S Kurata, S Ikeda, S Teng, I Katoh et al. Prevention of ischemia

reperfusion injury by positive pulmonary venous pressure in isolated rat lung.

SHOCK, 2006, 25 (1) 66-72p. (IF2006=3.318)

3. Giamarellos-Bourboulis E, Zakynthinos S, Baziaka F, et al. Soluble triggering

receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis.

INTENSIVE CARE MEDICINE, 2006,32: 237-243 (IF2006=4.406)

4. Siachoque H., Ibanez M., Chuaire L., Garcia Ol, Gusman A, Florez L. Determination

of Interleukine-10 in cancer patients in stages Iii and Iv treated with dexamethasone.

Rev. Cienc. Salud. Bogota (Columbia), 2005, 3(2):148-155

5. Heper Y, Akahm H, Mistik R, Akgos S, Tore O, Goral G, Oral B, Budak F, Helvaci

S. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha

and interleukin-10 levels as diagnostic and prognostic parameters in patients with

community-acquired sepsis, severe sepsis and septic shock. Eur J Clin Microbiol

Infect Dis, 2006, 25: 481-491. (IF2006=2.33)

6. Akker, Erica L. T. Ficoll-separated mononuclear cells from sepsis patients are

contaminated with granulocytes Intensive Care Med. 2008; 34 (5):912-916

(IF2008=5.055) 7. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunction in the

septic patient: a new skin for the old ceremony. Molecular medicine, 2008, 14(1-2):

64-78. (IF2006=2.708)

8. Van den Akker ELT, Baan C., Van der Berg B., Russcher H., Joosten K., Hokken-

Koelega A, Lambert s., Koper J. Ficoll-separated monunuclear cells from sepsis

patients are contaminated with granolocytes. Intensive Care Medicine, 2008,DOI

10.1007/s00134-007-0989-0 (IF2007=4.623)

9. Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG et al. Interleukin-

2, interleukin-12, and interferon- levels and risk of young adult Hodgkin lymphoma.

Blood, 2008, vol.111: 3377-3382 (IF2007=10.896)

10. Jeurink PV, Noguera CL, Savelkoul H, Wichers H. Immunomodulatory capacity of

fungal proteins on the cytokine production of human peripheral blood mononuclear

cells. Int Immunopharmacology, 2008, 8: 1124-1133. (IF2008=2.157)

11. Nalos M, Huang S, Sluyter R, Khan A, Santner-Nanan B, Nanan R, mclean A. “Host

tissue damage” signal ATP impairs IL-12 and IFNγ secretion in LPS stimulated

whole human blood. Intensive Care Medicine, 2008, 34: 1891-1897(IF2007=4.623)

12. Wu Huang-Pin, Chen C, Hsieh H, Liu Y. Effects of insulin and glucose on cytokine

production from peripheral blood mononuclear cells. Chang Gung Med J, 2008, 31:

253-258.

13. Prescilla V. Jeurink. A multidisciplinary study of allergy. Mouse models, immune

modulation and lifestyle. PhD thesis, Wageningen University, The Netherlands, 2008.

ISBN: 978-90-8504-961-6. http://library.wur.nl/wda/dissertations/dis4521.pdf

14. Nanas S, Gerovasili V, Renieris P, et al. Non-invasive assessment of the

microcirculation in critically ill patients. Anaesthesia and Intensive Care, 2009, 37:

733-739. (IF2007=0.896)

15. Abdel-Hady H, El-Naggar M, El-Nady G, Badr R, El-Daker M. Genetic

polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset

blood streem infections. Journal of pediatric infectious diseases 2009, 4: 357-365

16. Bruns, Anke H.W.; Wunderink, R. G. Association of Genetic Variation with

Pneumonia. Current respiratory medicine reviews. 2010, 6(1): 36-44

17. Bruns A., Grant W Waterer, Richard G Wunderink. Genetic risk of acute pulmonary

infections and sepsis. Expert Review of Respiratory Medicine 2010; 4 (2): 229-38

(IF2010=0.791) 18. Mokart, D., Leone, M., Sannini, Brun, J.P., Turrini, O., Lelong, B., Houvenaeghel,

G., Blache, J.L., Mege, J.L., Martin, C. Reduced interleukin-12 release from

stimulated monocytes in patients with sepsis after major cancer surgery. Acta

Anaesthesiologica Scandinavica, 2010, Vol. 54:643-648 (IF2007=1.953)

19. Wu Huang-Pin, Sheng-Fong Kuo, Shao-Yun Wu, Duen-Yau Chuang. "High

interleukin-12 production from stimulated peripheral blood mononuclear cells of type

2 diabetes patients."; Cytokine. 2010 , 51: 298-304 (IF2008=2.214)

20. Chen JN, Ma CY, Tsai PF, Wang YT, Wu JS. In vitro antitumor and

immunomodulatory effects of the protein PCP-3A from mushroom pleurotus

citrinopileatus. Journal of agricultural and food chemistry, 2010, 58: 12117-122

(IF2010=2.816)

21. Wu Huang-Pin, Chi-Chung Shih, Chun-Yao Lin, Chung-Ching Hua and Duen-Yau

Chuang. Serial increase of IL-12 response and human leukocyte antigen-DR

expression in severe sepsis survivors. Critical Care. 2011,

15:R224 doi:10.1186/cc10464(IF2008=4.60)

22. Kendra N. Iskander, Marcin F. Osuchowski, Deborah J. Stearns-Kurosawa,

Shinichiro Kurosawa, David Stepien, Catherine Valentine and Daniel G. Remick;

Sepsis – Multiple Abnormalities, Heterogeneous Responses, Evolving

Understanding; Physiological Reviews, 93 (3) pp 1247-1288, 2013,. (IF2011=26.866)

23. Schulte W, , J Bernhagen, R Bucala. Cytokines in Sepsis: Potent Immunoregulators

and Potential Therapeutic Targets – an Updated View. Mediators of Inflammation,

art. No. 165974, 2013 http://dx.doi.org/10.1155/2013/165974(IF2011=3.882)

24. Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swiesze)wska, Piotr Trzonkowski,

Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska, and Anna Balcerska.

Serum IL-10 and IL-12 levels reflect the response to chemotherapy but are influenced

by G-CSF therapy and sepsis in children with soft tissue sarcomas. Postepy Hig Med

Dosw (online), 2013; tom 67: 517-528. (IF2011=0.654

25. Chu CM, Kuo SF, Hua CC, Wu SY, Chuang DY, Wu HP. Glucose increases

interleukin-12 gene expression and production in stimulated peripheral blood

mononuclear cells of type 2 diabetes patients. Biomed J 2014;37:293-7(IF2013=0.

465)

26. Angelo HD, Gomes Silva IF, Oliveira RD et al. Interleukin-18, interleukin-12B and

interferon-γ gene polymorphisms in Brazilian patients with rheumatoid arthritis: a

pilot study. Tissue antigen 2015, 86:276-278 DOI: 10.1111/tan.12645 (IF2014=2.137)

27. He P, Shen N, Jiang X, Sun H, Zhou Z, Zhang Y, Gao G, Ren K.Association of IL-

12a and IL-12B gene polymorphisms with rheumatoid arthritis: A meta-analysis. Clin

Exp Immunol. 2015 Apr; 180(1): 83–89. doi: 10.1111/cei.12563 (IF2014=3.037)

28. Huang-Pin Wu, Chi-Chung Shih, Chien-Ming Chu, Chih-Yu Huang, Chung-Ching

Hua, Yu-Chih Liu, Duen-Yau Chuang. Effect of interleukin-17 on in vitro cytokine

production in healthy controls and patients with severe sepsis. Journal of the

Formosan Medical Association. 2016, 114: 125--1257

http://dx.doi.org/10.1016/j.jfma.2014.09.009; (IF2013=1. 695)

29. Huang-Pin Wu, Chi-Chung Shih, Duen-Yau Chuang, and Tien-Hsing Chen, “Low-

Dose Steroid Therapy Is Associated with Decreased IL-12 Production in PBMCs of

Severe Septic Patients,” Mediators of Inflammation, vol. 2016, Article ID 1796094, 8

pages, 2016. doi:10.1155/2016/1796094 (IF2015=3. 418)

30. Tapader R, Bose D, Basu P et al., Role in proinflammatory response of YghJ, a

secreted metalloprotease from neonatal septicemic Escherichia coli. International

Journal of medical microbiology. 2016, 306:554-565

http://dx.doi.org/10.1016/j.ijmm.2016.06.003 (IF2015=3. 898)

31. Fanny Poujol. Immunod´epression acquise en r´eanimation : approche exp´erimentale

et cliniques des alt´erations lymphocytaires induites lors des syndromes septiques.

Immunologie. PhDthesis, Universit´e de Lyon, 2016. Fran¸cais.

Цитирана статия:

Stanilov N, Miteva L, Mintchev N, Stanilova S. High expression of Foxp3, IL-23p19

and surviving mRNA in colorectal carcinoma. International Journal of Colorectal

Disease. 2009, 24: 151-157.

Цитиращи автори и статии:

32. Bardou M., Barkun A, Martel M. Effect of statin therapy on colorectal cancer.

Gut, 2010, doi:10.1136/gut.2009.190900 (IF2008=10.015)

33. Reay, Ja'Nean Christine. Therapeutic Gene Therapy for Cancer with Interleukin-23,

PhD Dissertation, Pittsuburgh University, School of Medicine, 2010

34. Ljujic B, G Radosavljevic, I Jovanovic, S Elevated Serum Level of IL-23 Correlates

with Expression of VEGF in Human Colorectal Carcinoma. Archives of Medical Res,

2010, 41,182-189 (IF2008=1. 772)

35. Bobe, G, G Murphy, P S Albert, L B Sansbury, E Lanza, A Schatzkin, N H Colburn

and A J Cross (2010) Serum cytokine concentrations, flavonol intake and colorectal

adenoma recurrence in the Polyp Prevention Trial. British Journal of Cancer, 103,

1453-1461 doi:10.1038/sj.bjc.6605915(IF2008 =4.846)

36. Erreni, M, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) and

inflammation in colorectal cancer. Cancer Microenvironment, 2011, 4, 141-154, DOI:

10.1007/s12307-010-0052-5 (IF2010=0.645)

37. Cao Weiguo, W Yang, H Li, G Lou et al., Using detection of survivin-expressing

circulating tumor cells in peripheral blood to predict tumor recurrence following

curative resection of gastric cancer. Journal of Surgical Oncology. 2011, 103,110-115

(IF2008 =2.384)

38. Adamo V, T Franchina1, PL Minciullo, E Pace, F Colonese, GRR Ricciardi, S Saitta,

M Ferraro, G Spatari, S Gangemi. Role of Interleukin-23 circulating levels increase in

resected colorectal cancer before and after chemotherapy: preliminary data and future

perspectives. Journal of cellular physiology. 2011, 226, 3032-3034.

DOI: 10.1002/jcp.22653 (IF2010 =3. 986)

39. Teng M, von Scheidt B, Duret H, Towne J, Smyth M Anti-IL-23 monoclonal

antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor

growth and metastases. Cancer Research 2011; 71, 2077 doi: 10.1158/0008-

5472.CAN-10-3994 (IF2010 =8. 234)

40. Lan Feng, Le Zhang, Junchao Wu, Jie Zhang, Sen Zhang, Kai Li, Yanyu Qi1 and

Ping Lin. IL-23/IL-23R: potential mediator of intestinal tumor progression from

adenomatous polyps to colorectal carcinoma. International Journal of Colorectal

Disease 2011, doi: 10.1007/s00384-011-1232-6 (IF2009 =2.102)

41. Gutler J Samuel. Regulation of gene expression in cancer: the relation of STAT-1,

MMp-1 and MMP-3. PhD Dissertation, Griffith University, School of Medicine, 2011

42. MY Huang, HC Chen, IP Yang, HL Tsai, TN Wang et al., Tumorigenesis and tumor

progression related gene expression profils in colorectal cancer. Cancer Biomarkers,

2013,vol 13: 269-279 (IF2012 =0.972)

43. Xue Q, Hui J. Progress of the relationship between Foxp3 and malignant tumor

treatment. Chinese Journal of Clinical Oncology, 2014, 41: 608-610

44. Wang, J. , Lv, Y., Meng, J., Song, J., Zhang, L., Tie, Y. Expression and clinical

significance of IL-23 and IL-17 in patients with colorectal cancer. Chinese Journal of

Clinical Oncology, 2014, 41: 580-584.

45. Melina Helbling, Anne Lukesch, Aladin Haimovici, Eva Karamitopoulou, Martin D.

Berger, Marion Hädrich, Makhmud Mallaev, Beat Schnüriger, Viktor H. Koelzer,

Heather Dawson, Markus Borner, Rupert Langer, Robert Rosenberg, Ulrich Nitsche,

Daniel Inderbitzin, Alessandro Lugli, Mario P. Tschan, Inti Zlobec. Investigation of

IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable

prognostic factor in colorectal cancer: a retrospective multicenter study of 675

patients. Oncotargets, 2014, 5(13), 4671-4682. (IF2013 = 6.627)

46. Li, Y., Zhou, Y., Zheng, J., Niu, C., Liu, B., Wang, M., Hou, C. (2015).

Downregulation of survivin inhibits proliferation and migration of human gastric

carcinoma cells. International Journal of Clinical and Experimental Pathology,8(2),

1731–1736. (IF2013 = 1. 783)

47. H Zhang, S Zhang. The expression of Foxp3 and TLR4 in cervical cancer: association

with immune escape and clinical pathology. Archives of Gynecology and Obstetrics,

2017; 295:705-712, doi:10.1007/s00404-016-4277-5(IF2015 = 1. 680)

Цитирана статия:

Miteva L, Stanilov N., Deliyski T, Minchev N., Stanilova S. Association of

polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine

serum level with colorectal cancer. Cancer Investigation, 2009, 27(9):924-931,

DOI: 10.1080/07357900902918486

Цитиращи автори и статии:

48. Long TM and Raufman J-P. The diagnostic and prognostic role of cytokines in colon

cancer. Gastrointestinal Cancer: Targets and Therapy 2011:1, 27–39

49. Nemat A Husein, Naeima M. H. Yousef. MICROBIAL POPULATION OF SOIL

CONTAMINATED WITH PETROLEUM DERIVATIVES AND MOLECULAR

IDENTIFICATION OF ASPERGILLUS NIGER. Egypt. J. Exp. Biol. (Bot.). 2011;

7(1): 25-34.

50. Chaaben A. Ben, M. Busson, H. Douik, W. Boukouaci, T. Mamoghli, L. Chaouch, L.

Harzallah, S. Dorra, C. Fortier, A. Ghanem, D. Charron, R. Krishnamoorthy, F.

Guemira, R. Tamouza. Association of IL-12p40 +1188 A/C polymorphism with

nasopharyngeal cancer risk and tumor extension. Tissue antigens, 2011, 78, 148-151.

(IF2010=3.024)

51. Diakowska D, Grabowski K, Nienartowicz M, Szelachowski P, . Markocka-Mączka

K. Serum and tissue levels of interleukin-12 and interleukin-18 in intestinal type

gastric cancer. Gastroenterologia Polska, 2011, 18; 103-108

52. SJ CUTLER. Regulation of Gene Expression in Cancer: The Relationship of STAT1,

MMP-1 and MMP-3; PhD thesis; Griffits University; 2011

53. Sima Xiutian, Jianguo Xu, Qiang Li, Lin Luo, Jiangang Liu, and Chao You. Gene–

Gene Interactions Between Interleukin-12A and Interleukin-12B with the Risk of

Brain Tumor. DNA and Cell Biology. 2012, 31(2): 219-223.,

doi:10.1089/dna.2011.1331. (IF2010= 2.159)

54. Huang Z.Q, Wang J.L, Pan G, Wei YS. Association of single nucleotide

polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk. Clinical

Biochemistry. 2012, 45: 54-58. (IF2010=2.043)

55. Yuzhalini A.E. and Kutikhin A. Interleukin-12: Clinical usage and molecular

markers of cancer susceptibility. Growth Factors, June 2012; 30(3): 176–191(IF2010=

2.800)

56. Yi-Peng Tao, Wan-Ling Wang, Song-Yue Li, Jian Zhang, Qi-Zhong Shi, Fen Zhao

and Bao-Sheng Zhao. Associations between polymorphisms in IL-12A, IL-12B, IL-

12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.

Journal of Cancer Research and clinical oncology.2012, 138 DOI: 10.1007/s00432-012-

1269-0 (IF2011=2. 585)

57. Zhou, L., Yao, F., Luan, H., Wang, Y., Dong, X., Zhou, W., Wang, Q. Functional

polymorphisms in the interleukin-12 gene contribute to cancer risk: Evidence from a

meta-analysis of 18 case-control studies , 2012, Gene 510 (1) , pp. 71-77(IF2011=2.

341)

58. Chen H, S Cheng, J Wang, C Cao, H Bunjhoo, W Xiong et al. Interleukin-12B

rs3212227 polymorphism and cancer risk: a meta-analysis. Molecular Biology

Reports, 2012, DOI: 10.1007/s11033-012-1899-y (IF2011=2. 925)

59. Yang Z. Liang Y. Qin B. Zhong R. Meta-Analysis of the Association between the IL-

12B +1188 A/C Polymorphism and Cancer Risk. Onkologie 2013; 36:470-475

(DOI:10.1159/000354671) (IF2012=1.025)

60. Junli Wang, Legen Nong, Yesheng Wei, Shanyu Qin, You Zhou, and Yujin Tang.

Association of Interleukin-12 Polymorphisms and Serum IL-12p40 Levels with

Osteosarcoma Risk. DNA and Cell Biology. 2013; doi:10.1089/dna.2013.2098;

(IF2012=2.344)

61. Eliana Guerriero, Francesca Capone, Fabiola Rusolo, Giovanni Colonna, Giuseppe

Castello, Susan Costantini. Dissimilar cytokine patterns in different human liver and

colon cancer cell lines. Cytokine, 2013, 64 (2) , pp. 584-589

http://dx.doi.org/10.1016/j.cyto.2013.09.002 (IF2012=2.518)

62. Peng Q., Li S, Lao X, Chen Z, Li R, Qin X. Interleukin-12B +1188A/C

polymorphism contributes to increased hepatocellular carcinoma susceptibility:

Evidence from a meta-analysis. Clinics and Research in Hepatology and

Gastroenterology. DOI: 10.1016/j.clinre.2014.09.002. 2014 (IF2013=1.983)

63. Ruifen Sun, Fu Jia, Yundan Liang, Lijuan Li, Peng Bai, Fang Yuan, Linbo Gao and

Lin Zhang. Interaction analysis of IL-12A and IL-12B polymorphisms with the risk

of colorectal cancer. Tumor Biology, 2015, 36:9295-9301; Doi: 10.1007/s13277-015-

3685-7 (IF2014=3.611)

64. Eberhard C., Haas J-P., Girschick H., Schwarz T., Morbach H., Rosen-Wolff A et al.,

No association of IL-12p40 pro1.1 polymorphism with juvenile idiopathic arthritis.

Pediatric Rheumatology; Dec. 2015. Doi 10.1186/s12969-015-0059-z (IF2014=1.607)

65. Jafarzadeh A; Minaee K; Farsinejad AR; Nemati M; Khosravimashizi A; Daneshvar

H; Mohammadi M; Sheikhi A; Ghaderi A. Evaluation of the circulating levels of IL-

12 and IL-33 in patients with breast cancer: influences of the tumor stages and

cytokine gene polymorphisms. Iranian Journal of Biomedical science. 2015, 18:

1189-1198 (IF2014=1.228)

66. Richter C, Herrero San Juan M, Weigmann B, Bergis D, Dauber K, Muders MH,

Baretton GB, Pfeilschifter JM, Bonig H, Brenner S and Radeke HH (2017) Defective

IL-23/IL-17 Axis Protects p47phox−/− Mice from Colon Cancer. Front. Immunol.

2017; 8:44. doi: 10.3389/fimmu.2017.00044 (IF2015=5.695)

Цитирана статия:

Stanilov N., Miteva L, Deliyski T, Jovchev J, Stanilova S. Advanced colorectal

cancer is assosiated with enhanced Interleukin-23 and Interleukin -10 serum level.

LabMedicine, 2010, 41 (3): 159-163

Цитиращи автори и статии:

67. Teng MWL, von Scheidt B, Duret H, Towne JE, Smyth M. Anti-IL-23 monoclonal

antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor

growth and metastases. Cancer Research, 2011, 71:2077-2086 (IF2010= 4.310)

68. Takami Sato, Mizue Terai, Yutaka Tamura, Vitali Alexeev and Michael J.

Mastrangelo, et al. Interleukin 10 in the tumor microenvironment: a target for

anticancer immunotherapy. Immunologic Research, 2011, Volume 51, Numbers 2-3,

Pages 170-182(IF2010= 3.383)

69. Xu X, Ma S, Tao M. Correlation between Th17 cells and human tumors. Chinese

Journal of Clinical Oncology. 2011, 38, 680-683. (IF2010= 0.383)

70. SJ CUTLER. Regulation of Gene Expression in Cancer: The Relationship of STAT1,

MMP-1 and MMP-3; PhD thesis; Griffits University; 2011

71. Andrzej Marszałek, Łukasz Szylberg, Ewa Wiśniewska, Marlena Janiczek. Impact of

COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesisin the large

bowel. Pol. J Pathol 2012; 221-227. (IF2011=0. 347)

72. Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swieszewska, Piotr Trzonkowski,

Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska, and Anna Balcerska.

Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric

soft tissue sarcomas, Biomarkers, 2013, 18:204-215,

doi:10.3109/1354750X.2013.764351(IF2012=1. 879)

73. Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swieszewska, Piotr Trzonkowski,

Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska, and Anna Balcerska.

Serum IL-10 and IL-12 levels reflect the response to chemotherapy but are influenced

by G-CSF therapy and sepsis in children with soft tissue sarcomas. Postepy Hig Med

Dosw (online), 2013; tom 67: 517-528. (IF2011=0.654)

74. Yan Wang, Xiao-Hong Liu, Yue-Hong Li, Ou Li The paradox of IL-10-mediated

modulation in cervical cancer (Review) Biomedical Reports 1: 347-351, 2013

75. Eliana Guerriero, Francesca Capone, Fabiola Rusolo, Giovanni Colonna, Giuseppe

Castello, Susan Costantini. Dissimilar cytokine patterns in different human liver and

colon cancer cell lines. Cytokine, 2013, 64 (2) , pp. 584-589

http://dx.doi.org/10.1016/j.cyto.2013.09.002 (IF2012=2.518)

76. Yang, Yan, "CHARACTERIZING THE EFFECT OF DASATINIB ON ANTI-TUMOR IMMUNE

RESPONSE AND EXPLORING THE POTENTIAL OF COMBINING TARGETED THERAPY AND

IMMUNOTHERAPY IN A C-KIT MUTANT MASTOCYTOMA MODEL" (2013). UT GSBS

Dissertations and Theses (Open Access). Paper 413.

77. Lee Hae mi, Kyung-Sup Kim, Jongsun Kim. A comparative study of the effects of

inhibitory cytokines on human natural killer cells and the mechanistic features of

transforming growth factor-beta. Cellular Immunology 290 (2014) 52–61.

(IF2012=1.743)

78. Yang B, Kang H, Fung A, Zhao H, Wang T and Ma D. The Role of Interleukin 17 in

Tumour Proliferation, Angiogenesis, and Metastasis. Mediators of

Inflammation.Volume 2014, Article ID 623759, (IF2012=3.882)

79. Łukasz Szylberg, Marlena Janiczek, Aneta Popiel, Andrzej Marszałek. Large Bowel

Genetic Background and Inflammatory Processes in Carcinogenesis – Systematic

Review. Adv Clin Exp Med, 2015, 24(4):555-561 · DOI: 10.17219/acem. (IF2014=1.

095)

80. Lourimar Viana Nascimento F. de Sousa, Vera Lúcia Santos, Andrea de Souza

Monteiro et al. Isolation and identification of Candida species in patients with

orogastric cancer: susceptibility to antifungal drugs, attributes of virulence in vitro

and immune response phenotype. BMC Infectious Diseases (2016) 16:86 DOI

10.1186/s12879-016-1431-4; (IF2014=2.613)

81. Kifah Jabbar Alyaqubi, Azhar Jasim AL-kaabi, Siham Jasim AL-kaabi. Plasma IL-10

Concentration and Its Role in the Pathogenesis of Acute Myeloid Leukemia: a

Prospective Study. Iraqi Journal of Biotechnology, 2016, Vol. 15, No. 1 , 61-67

82. Mager LF, Wasmer MH, Rau TT and Krebs P (2016) Cytokine-Induced Modulation

of Colorectal Cancer. Front. Oncol. 6:96. doi: 10.3389/fonc.2016.00096

83. NH Al-dulaimy, AJ Hassan, SM Al-Araji. Estimation of Interferon-α (IFN-α) and

Tumor Necrosis Factor-α (TNF-α) in Female Rats Immunized by Human Breast

Cancer Cell Line T47D. Journal of Babylon University/Pure and Applied Sciences/

No.(9)/ Vol.(24): 2016

Цитирана статия:

Stanilova S, Miteva L, Stanilov S, Stefanov Ch, Karakolev Z, InterLeukin-12B

Polymorphisms in association with sucseptibility to severe sepsis. LabMedicine,

2010, 41 (1): 47-51

Цитиращи автори и статии:

84. Karp G, Perl Y, Fuch L, Almog Y, Klein M, Vodonos A, Dreiher J, Talmor D,

Codish S and Novack V. Ethnicity and sepsis characteristics and outcome. Population

based study. European Journal of Internal medicine, 2013, 24:34-39 (IF2011= 2.0)

Цитирана статия:

Stanilov N., Stankova N, Miteva L, Jovchev J, Deliyski T, Stanilova S. Role of IL-

12p40 and IL-10 in progression of colorectal cancer. Trakia Journal of Sciences,

2010, vol. 8, suppl. 2, pp 132-136

Цитиращи автори и статии:

85 . Andrzej Marszałek, Łukasz Szylberg, Ewa Wiśniewska, Marlena Janiczek. Impact of

COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesisin the large

bowel. Pol. J Pathol 2012; 221-227. (IF2011=0. 347)

86. Abdulla AR, Mohammed A, Al-Rawaq K, Ibraheem A. IL-10 serum level estimation

in Iraqi colorectal and gastric cancer patients. J Fac Med Baghdad, 2012, 54 (2), 167-

171.

87. Ahmed, S. A., Aly, H. F., & Omar, O. S. (2013). World Journal of Pharmaceutical

research.

88. Łukasz Szylberg, Marlena Janiczek, Aneta Popiel, Andrzej Marszałek. Large Bowel

Genetic Background and Inflammatory Processes in Carcinogenesis – Systematic

Review. Adv Clin Exp Med, 2015, 24, DOI: 10.17219/acem. (IF2014=1. 095)

Цитирана статия:

Stanilov N., L. Miteva, Stankova N, Jovchev J, Deliyski T, Stanilova S. Role of IL-

12p40 and IL-10 in progression of colorectal cancer. Kirurgia, 2010, 4-5: 26-29,

Цитиращи автори и статии:

89. 376 . Yuzhalin AE, Kutikhin AG. Interleukins in cancer biology: their heterogeneous

role. p223-260 in Book; Doi: 10.1016/B978-0-12-801121-8.00007-5. 2014;

ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD, 24-28 OVAL ROAD,

LONDON NW1 7DX, ENGLAND

90. Pathak S, Meng W, Nandy S, Ping J, Bisqin A, Helmfors L, Waldmann P, Sun X-F.

Radiation and SN38 treatments modulate the expression of microRNAs, cytokines

and chemokines in colon cancer cells in a p53-directed manner. Oncotargets 2015,

42: 44758-44780 (IF2014=6.359)

Цитирана статия:

Karakolev I., Stanilov N., Miteva L, Jovchev J, Dobreva Z, Stanilova S. Expression of

IGF-1R mRNA in colorectal carcinoma patients. Biotechnology and Biotechnology

equipment. 2012, 26: 89-95

Цитиращи автори и статии

91. Al-Moghrabi et al., The molecular significance of methylated BRCA1 promoter in

white blood cells of cancer-free females. BMC Cancer 2014, 14:830 (IF2014= 3. 362)

Цитирана статия:

Stanilov N., Miteva L, Dobreva Z, Jovchev J, Stanilova S. Monocytes expression of

IL-12 related and IL-10 genes in association with development of colorectal cancer.

Molecular Biology Reports, 2012, Dec.39(12):10895-902, DOI: 10.1007/s11033-012-

1987-z

Цитиращи автори и статии:

92. Junli Wang, Legen Nong, Yesheng Wei, Shanyu Qin, You Zhou, and Yujin Tang.

Association of Interleukin-12 Polymorphisms and Serum IL-12p40 Levels with

Osteosarcoma Risk. DNA and Cell Biology. 2013; doi:10.1089/dna.2013.2098;

(IF2012=2.344)

93. O’Toole A, A J Michielsen, B Nolan, M Tosetto, K Sheahan, H E Mulcahy, D C

Winter, J M Hyland, P R O'Connell, D Fennelly, D O'Donoghue, J O'Sullivan, G A

Doherty and E J Ryan. Tumour microenvironment of both early- and late-stage

colorectal cancer is equally immunosuppressive. British Journal of Cancer ,

(24 July 2014) | doi:10.1038/bjc.2014.367, (IF2013=4.817)

94. Yuzhalin AE, Kutikhin AG. Interleukins in cancer biology: their heterogeneous role.

p223-260 in Book; Doi: 10.1016/B978-0-12-801121-8.00007-5. 2014; ACADEMIC

PRESS LTD-ELSEVIER SCIENCE LTD, 24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND

95. Ruifen Sun, Fu Jia, Yundan Liang, Lijuan Li, Peng Bai, Fang Yuan, Linbo Gao and

Lin Zhang. Interaction analysis of IL-12A and IL-12B polymorphisms with the risk

of colorectal cancer. Tumor Biology, 2015, 36:9295-9301; Doi: 10.1007/s13277-015-

3685-7 (IF2014=3.611)

96. Colineau L, Rouers A, Yamamoto T, Xu Y, Urrutia A, Pham H-P et al., HIV-Infected

Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell

Maturation. PLOS One, 2015, DOI: 10.1371/journal.pone.0140978; (IF2014=3,234)

Цитирана статия:

Miteva L, Stanilov N, Tashko S Deliysky, Spaska Stanilova. Significance of -

1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10

expression", Tumor Biology, 2014, DOI: 10.1007/s13277-014-2589-2 (IF2013= 2.84)

Цитиращи автори и статии:

97. Slattery M, Lundgreen A. The influence of the CHIEF pathway on colorectal cancer-

specific mortality. 2014; PLOS one, DOI: 10.1371/journal.pone.0116169 (IF2013=

3.534) 98. Hong-Xia Li, Yuan-Yuan Li, Zheng-Jun Song, Shui-Xiang He, Qin-Yue Guo.

Association between IL-8 -251A/T and IL-10 -1082A/G genetic polymorphisms and

susceptibility to colorectal cancer: A case-control study in a population in

Shaanxi.World Chinese Journal of Digestology 23(7): 1184-1190, 2015

99. Hiroki C, Amarante M, Petenuci D, et al. IL-10 gene polymorphism and influence of

chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia

patients: IL-10 polymorphism and plasma levels in leukemia patients. Blood Cells,

Molecules, and Diseases. 2015, 55:168-172. (IF2013=2,646)

100. Gentile Luciana Boffoni et al., Modulation of cytokines production by

indomethacin acute dose during the evolution of erhlich ascites tumor in mice.

Mediator of inflammation. 1. Vol.1.2015,Article ID 924028, (IF2014=3,236)

101. X.-H. LU, G.-X. MAO, Y.-Y. ZHANG, Y.-S. CHU, H.-X. YUAN, X.-Q. ZHU.

Association between variants of IL-8 and IL-10 genes, and efficacy of transcatheter

arterial chemoembolization and subsequent prognosis in patients with liver cancer.

European Review for Medical and Pharmacological Sciences 2015; 19: 3218-3223

(IF2014=1,213)

102. Li C, Luo X, Lin Y, Tang X, Ling L, Wang L, Jiang Y. A Higher Frequency of

CD14+CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer. PLOS

One, 2015, DOI: 10.1371/journal.pone.0141817. (IF2014=3,234)

103. Nai-Guo Wang, Da-Chuan Wang, Bing-Yi Tan, Feng Wang, Ze-Nong Yuan.

TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing

spondylitis in Chinese Han population. Int J Clin Exp Pathol 2015;8(11):15204-

15209. (IF2014=1,891)

104. Buchert M, CJ Burns and M Ernst. Targeting JAK kinase in solid tumors:

emerging opportunities and challenges. Oncogene (2016), 35: 939-951.

doi:10.1038/onc.2015.150 (IF2013= 8.559) 105. Peng MW, Lu SQ, Liu J, Dong CY. Role of IL-10 polymorphisms in

susceptibility to hepatitis B virus-related hepatocellular carcinoma. Genetics and

Molecular Research, 2016, 15 (1): gmr.15017984 (IF2014= 0.775)

106. Mager LF, Wasmer MH, Rau TT and Krebs P (2016) Cytokine-Induced

Modulation of Colorectal Cancer. Front. Oncol. 6:96. doi: 10.3389/fonc.2016.00096

107. Shi YH, Zhao DM, Wang YF et al. The association of three promoter

polymorphisms in interleukin-10 gene with the risk for colorectal cancer and

hepatocellular carcinoma: A meta-analysis. Scientific reports. 2016,6,

doi:10.1038/srep30308 (IF2015= 5.228)

108. Liu L, Zheng F. IL-10-1082A/G, -592C/A, and -819T/C polymorphisms in

association with lung cancer susceptibility: a meta-analysis. OncoTargets and

Therapy; 2016; 9:6083-6091; DOI: 10.2147/OTT.S118481 (IF2015= 2.272)

109. Zhang S, Wang Y, Liu C, et al.Polymorphisms in the interleukin-10 gene and

hepatocellular carcinoma: An updated meta-analysis of 12 case-control studies.

International journal of clinical and experimental medicine. 2016, 9: 17140-17152.

(IF2015= 1.075)

110. Vaddi Kris. Immunotherapy for gastrointestinal cancer (book chapter). In: “The

Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal

Cancers”, 147-186; 2017, DOI:10.1007/978-3-319-43063-8_7

Цитирана статия:

Stanilov Noyko S., Lyuba D. Miteva, Zlatka G. Dobreva, Jovcho P. Jovchev,

Spaska A. Stanilova. Colorectal cancer severity and survival in correlation with

TNF-α. 2014, Biotechnology and Biotechnology equipment, 2014, 28:911-917; doi:

10.1080/13102818.2014.965047

Цитиращи автори и статии:

111. Kayhan Erturk & Didem Tastekin & Murat Serilmez & Elif Bilgin & Hamza

Ugur Bozbey & Sezai Vatansever. Clinical significance of serum interleukin-29,

interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.

Tumor Biology, 2015, DOI 10.1007/s13277-015-3829-9 (IF2014= 3. 611)

112. Kiyomi A, Makita M, Ozeki T et al., Characterization and Clinical Implication of

Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor

Tissues Resected from Breast Cancer Patients. Translational oncology, 2015, 8:318-

326. (IF2014= 2.884)

113. Tony Ibrahim, Khalil Saleh, Viviane Track-smayra, Nelly Ziade, Dalia Sarraf,

Charbel Yazbeck, Nadine Khalife, Fadi Nasr. Late Recurrence of Low-Risk Stage II

Colorectal Cancer Shortly After Etanercept. Journal of Gastrointestinal Cancer. 2016,

47:506-508, DOI 10.1007/s12029-015-9788-y (IF2014= 0.38)

114. Palma S., Zwenger A, Croce M., Abba M, Lacunsa E. From molecular biology to

clinical trials. Towards a personalized colorectal cancer therapy. Clinical colorectal

cancer. 2016, doi:10.1016/j.clcc.2015.11.001 (IF2014= 2.813)

115. Mager LF, Wasmer MH, Rau TT and Krebs P (2016) Cytokine-Induced

Modulation of Colorectal Cancer. Front. Oncol. 6:96. doi: 10.3389/fonc.2016.00096

116. Mujeeb Z Banday, Henah M Balkhi, Z Hamida, Aga S Sameerb, Nissar A.

Chowdric, Eihtisham U Haqa. Tumor necrosis factor-α (TNF-α)-308G/A Promoter

Polymorphism in Colorectal Cancer in ethnic Kashmiri population - a case control

study in a detailed perspective. Meta Gene, 2016, doi:10.1016/j.mgene.2016.06.001;

(IF2014= 0.611)

117. I.A. Gutiérrez-Hurtado, A.M. Puebla-Pérez, J.I. Delgado-Saucedo, L.E. Figuera,

G.M. Zúñiga-González, K. Gomez-Mariscal, C.A. Ronquillo-Carreón and M.P.

Gallegos-Arreola. Association between TNF-α -308G>A and -238G>A gene

polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients.

Genetics and Molecular Research, 2016, 15 (2): gmr.15028199 (IF2015= 0.775)

118. Wang Y, Zhu X, Xuan C. Micro-RNA-505 inhibits proliferation and

promotesapoptosis of colorectal cancer cells. International Journal of clinical and

experimental medicine. 2016, 9:10488-10496 (IF2015= 1.075)

Цитирана статия:

Stanilov N S., Karakolev, I.A., Deliysky, T.S, Jovchev, J.P., Stanilova, S.A.

Association of insulin-like growth factor-I receptor polymorphism with colorectal

cancer development. (2014) Molecular Biology Reports, 41 (12), pp. 8099-8106.

doi: 10.1007/s11033-014-3708-2

Цитиращи автори и статии:

119. Małgorzata Andrzejewska. Tkankowa ekspresja insulinopodobnego czynnika

wzrostu 1 (IGF-1) w nowotworach jelita grubego (Tissue expression of insulin-like

growth factor 1 (IGF-1) in colorectal carcinoma) PhD thesis, Poznan, Uniwersytetu

Medycznego im. K. Marcinkowskiego w Poznaniu 2015

120. Han X, Hou S, Yang A. Correlation between IGFs-related proteins expression and

incidence of colorectal cancer in diabetic patients and related mechanisms. Medical

Science Monitor, 2016, 22:848-854 (IF2014= 1.433)

121. Yao C, Su L, Shan J, Zhu C, Liu L, Liu C et al. IGF/STAT3/NANOG/Slug

Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and

Stemness Maintenance in Colorectal Cancer. Stem Cell, 2016, 34:820-831. (IF2014=

6.523) 122. Rathore M, Dr. G.G. Kaushik. Regular original article Serum IGF-1 changes

associated with thyroid disorders. International Journal of Advanced Research (2016),

Volume 4, Issue 1, 668 – 674

123. Tu-Chen Liu, Ming-Ju Hsieh, Ming-Che Liu, Whei-Ling Chiang, Thomas Chang-

Yao Tsao and Shun-Fa Yang. The Clinical Significance of the El-Like Growth

Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal

Growth Factor Receptor Mutation. Int. J. Mol. Sci. 2016, 17(5), 763;

doi:10.3390/ijms17050763 (IF2014= 2.862)

124. Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adame, Anna Gozdzicka-

Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesis. Mutation research -

reviews, 2016,DOI: http://dx.doi.org/doi:10.1016/j.mrrev.2016.08.007 (IF2014= 5.

261) 125. Liu Liu et al. Association of insulin-like growth factor-1 receptor polymorphism

and insulin-like growth factor-1 plasma level with chronic immune thrombocytopenia

in Chinese population, Meta Gene; 2017; 11 (IR=0,339): 1-4 http://dx.doi.org/10.1016/j.mgene.2016.10.011

126. He J-R, Lai Y-M, Liu H-H, et al. Maternal IGF1 and IGF1R polymorphisms and

the risk of spontaneous preterm birth. J Clin Lab Anal. 2017;

00:e22125. https://doi.org/10.1002/jcla.22125 (IF2015= 1. 549)

Цитирана статия:

Stanilov N, Miteva L, Jovchev J, Cirovski G, Stanilova S. The prognostic value of

preoperative serum levels of IL-12p40 and IL-23 for survival of patients with

colorectal cancer. APMIS (2014) 122:1223–9. doi:10.1111/apm.12288

Цитиращи автори и статии:

127. Mager LF, Wasmer MH, Rau TT and Krebs P (2016) Cytokine-Induced

Modulation of Colorectal Cancer. Front. Oncol. (IR) 6:96. doi:

10.3389/fonc.2016.00096

128. Caner Cam, Bulent Karagoz, Tuba Muftuoglu, Oguz Bigi, Levent Emirzeoglu,

Serkan Celik, Alpaslan Ozgun, Tolga Tuncel, Cihan Top. The inflammatory cytokine

interleukin-23 is elevated in lung cancer, particularly small cell type. Contemp Oncol

(Pozn) 2016; 20 (3): 215–219 DOI: 10.5114/wo.2016.61562(IF2014= 0.89)

129. Radoslav Zagozdon, Witold Lasek. Biology of IL-12, chapter in Book:

Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology; 1-19, 2016,

Springer International Publishing; Doi: 10.1007/978-3-319-46906-5_1

Общ брой цитирания - 129

Брой цитирания в списания с IF - 100

Брой цитирания в списания без IF - 19

Брой цитирания в книги - 4

Брой цитирания в дисертации - 6